CTASC-Clinical Trials Management System
CTASC-临床试验管理系统
基本信息
- 批准号:7537474
- 负责人:
- 金额:$ 9.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-09-15 至 2009-06-14
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdvertisingAppendixArchitectureArchivesAreaAutomationAwardBudgetsBusinessesCapitalCase ManagementClientClinical DataClinical ResearchClinical TrialsCodeComputer softwareComputersConduct Clinical TrialsDataDatabasesDefectDepthDevelopmentDisease regressionDocumentationElementsEnsureEnvironmentFacility Construction Funding CategoryFailureGDF15 geneGuidelinesInternetJavaJob DescriptionJournalsKnowledgeLeadershipLearningLibrariesMailsMaintenanceManualsMarketingMarylandMedicalMethodologyMethodsModelingNumbersOnline SystemsPLAB ProteinPamphletsPerformancePeriodicalsPhasePositioning AttributePractice ManagementPreparationPriceProcessProduct PackagingPublic HealthPublicationsPublished CommentReaction TimeResearchResearch DesignResearch InfrastructureResearch PersonnelResourcesRunningSalesSecurityServicesSimulateSiteSolutionsSpeedStagingStandards of Weights and MeasuresStressStress TestsStructureSystemTechnologyTest ResultTestingTimeTimeLineTrainingTraining ProgramsUnited StatesUnited States Food and Drug AdministrationUpdateWorkWritingbasecommercializationconceptcostcost effectivedata managementdata modelingdaydesignexperienceimprovedinteroperabilitynew technologypreventprototypequality assurancerepairedsizesoftware developmenttool
项目摘要
DESCRIPTION (provided by applicant): The business of developing, testing, and approving new medical treatments for use in the U.S. has changed dramatically over the past 10 years. In recent years we have observed declining approvals, increasing costs, increasing regulatory process complexity, doubling of the number of new treatments being tested, and slowing of U.S. based recruitment. Together these forces have contributed to a significant increase in time to market for needed therapies.
We believe that the current regulatory requirements for conducting clinical trials are preventing small companies from testing many potentially beneficial therapies due to a lack of resources to conduct this testing. A new, simplified, cost effective technology solution is needed that will allow small research organizations to setup and conduct a clinical trial at an affordable price. If this new technology is based on time-tested standard computer driven processes, it will significantly increase the acceptability of data submissions to the FDA and file transfers to partner organizations.
Small researchers also tend not to have IT departments or large data centers to run these types of systems. To ensure the solution can be economically deployed, configured and integrated it should be provided through a Web browser using a Software as a Service (SaaS) model with a data model based on Clinical Data Interchange Standards Consortium (CDISC).
C-TASC is in a strong position to deliver this technology with a sustainable competitive advantage due to the experience and intellectual capital we have gained through years of managing these types of studies, our experience in developing Web-based technology to manage clinical trials, and our recent addition of technology leadership that has developed similar Web-based SaaS solutions for other large markets.
Creation of this technology will enable small research organizations to affordably conduct studies in a manner consistent with FDA standards, would speed many therapies to market and, in some cases, allow a therapy to come to market that would not have been affordable in the past.
PUBLIC HEALTH RELEVANCE: The current regulatory requirements for conducting clinical trials are preventing small companies from testing many potentially beneficial therapies due to a lack of resources to conduct this testing. A new simplified, cost effective technology solution is needed that will allow small research organizations to setup and run a clinical trial at an affordable price. C-TASC is developing this Clinical Trials Management System using Java and AJAX technologies to: enable small research organizations to affordably conduct studies in a manner consistent with FDA standards, speed many therapies to market and allow a therapy to come to market that would not have been affordable in the past.
描述(由申请人提供):在过去的10年里,在美国开发、测试和批准新药物治疗的业务发生了巨大的变化。近年来,我们观察到批准数量下降、成本增加、监管程序复杂性增加、新疗法测试数量翻倍以及美国招募速度放缓。这些力量共同促成了所需疗法上市时间的显著增加。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Margaret M Frederick其他文献
Margaret M Frederick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Margaret M Frederick', 18)}}的其他基金
BONE DENSITY IN CHILDHOOD STUDY - CLINICAL CENTER
儿童骨密度研究 - 临床中心
- 批准号:
7891903 - 财政年份:2001
- 资助金额:
$ 9.78万 - 项目类别:
BONE MINERAL DENSITY IN CHILDHOOD STUDY-275013328
儿童时期的骨矿物质密度研究-275013328
- 批准号:
6994755 - 财政年份:
- 资助金额:
$ 9.78万 - 项目类别:
BONE MINERAL DENSITY IN CHILDHOOD STUDY-275013328-275013328
儿童时期的骨矿物质密度研究-275013328-275013328
- 批准号:
7329624 - 财政年份:
- 资助金额:
$ 9.78万 - 项目类别:
相似国自然基金
小型类人猿合唱节奏的功能假说——宣
示社会关系(Social bond
advertising) ——验证研究
- 批准号:
- 批准年份:2025
- 资助金额:10.0 万元
- 项目类别:省市级项目
相似海外基金
SaTC: CORE: Medium: Increasing user autonomy and advertiser and platform responsibility in online advertising
SaTC:核心:中:增加在线广告中的用户自主权以及广告商和平台责任
- 批准号:
2318290 - 财政年份:2024
- 资助金额:
$ 9.78万 - 项目类别:
Continuing Grant
Marketing meaninglessness: critical anthropology of transnational advertising agencies
营销无意义:跨国广告公司的批判人类学
- 批准号:
2724869 - 财政年份:2024
- 资助金额:
$ 9.78万 - 项目类别:
Studentship
Innovation in Manufacturing to benefit the Marketing & Advertising Industry
制造创新有利于营销
- 批准号:
10064566 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:
Collaborative R&D
Collaborative Research: SaTC: CORE: Medium: Understanding and Combatting Impersonation Attacks and Data Leakage in Online Advertising
协作研究:SaTC:核心:媒介:理解和打击在线广告中的冒充攻击和数据泄露
- 批准号:
2247516 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:
Continuing Grant
A Dynamic Analysis of Advertising Interactive Techniques to Gain the Consumer Engagement
获得消费者参与的广告互动技术的动态分析
- 批准号:
23K01642 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Impact of Programmatic Advertising on Market Competition
程序化广告对市场竞争的影响
- 批准号:
23K18786 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Enabling profitable digital advertising for British SMEs with AI-powered multichannel ads brokerage service
通过人工智能驱动的多渠道广告经纪服务,为英国中小企业实现盈利的数字广告
- 批准号:
10070962 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:
Collaborative R&D
Cross-Platform Advertising Accountability
跨平台广告责任
- 批准号:
10071299 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:
Collaborative R&D
Improving the accountability of dark advertising on digital platforms
提高数字平台上暗广告的问责制
- 批准号:
IE230100647 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:
Early Career Industry Fellowships
The frequency and distribution of alcohol advertising on broadcast television in Canada and its potential implications for youth and public health policy
加拿大广播电视上酒类广告的频率和分布及其对青年和公共卫生政策的潜在影响
- 批准号:
493189 - 财政年份:2023
- 资助金额:
$ 9.78万 - 项目类别:














{{item.name}}会员




